Access Statistics for David Bardey

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Welfare Analysis of Genetic Testing in Health Insurance Markets with Adverse Selection and Prevention 0 0 0 35 0 0 0 26
A paradoxical risk aversion effect on the consumers’ demand for quality 0 0 0 5 0 0 0 75
Adverse Selection vs Discrimination Risk with Genetic Testing. An Experimental Approach 0 0 0 30 0 0 1 77
Adverse Selection vs Discrimination Risk with Genetic Testing. An Experimental Approach 0 0 0 50 0 0 0 127
Análisis económico de la normativa de libre competencia en Colombia 0 0 1 18 0 1 2 85
Characterization of the relevant market in the media industry: some new evidence! 1 1 1 70 1 1 1 68
Competencia en el sector de la salud: énfasis en el caso colombiano 0 0 1 60 0 0 6 185
Competition among health plans: a two-sided market approach 0 0 0 291 0 9 14 767
Competition between Managed Care Organizations and Indemnity Plans in Health Insurance Markets 0 0 0 100 0 1 2 100
Competition in Health Care Markets and Vertical Restraints 0 0 0 173 0 0 1 541
Competition in Health Care Markets and Vertical Restraints 0 0 0 52 0 0 0 220
Competition in two-sided markets with common network externalities 0 0 1 211 0 3 7 435
Competition in two-sided markets with common network externalities 0 0 0 166 0 0 1 239
Competition in two-sided markets with common network externalities 0 0 0 167 0 1 2 466
Concentration of the Mobile Telecommunications Markets and Countries' Competitiveness 0 0 10 72 0 0 36 215
Controlling Sellers Who Provide Advice: Regulation and Competition 0 0 1 53 1 3 5 145
Controlling Sellers Who Provide Advice: Regulation and Competition* 0 0 0 0 0 0 1 14
Controlling Sellers Who Provide Advice: Regulation and Competition* 0 0 0 0 0 1 2 10
Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at Least) in the Short Run? 0 0 0 11 0 0 0 23
Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run? 0 0 1 14 1 3 5 42
Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run? 0 0 0 11 0 0 1 39
Doctors' remuneration schemes and hospital competition in two-sided markets with common network externalities 0 0 0 74 0 0 0 147
Doctors' remuneration schemes and hospital competition in two-sided markets with common network externalities 0 0 0 60 0 1 3 105
Doctors´ remuneration schemes and hospital competition in two-sided markets with common network externalities 0 0 1 129 0 14 16 249
Drugs, Showrooms and Financial Products: Competition and Regulation When Sellers Provide Expert Advice 0 0 0 15 0 1 2 45
Drugs, Showrooms and Financial Products: Competition and Regulation When Sellers Provide Expert Advice 0 0 0 0 0 0 0 14
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 25 0 1 2 106
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 41 0 0 0 47
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 26 0 1 1 7
Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 0 0 0 37 0 0 2 60
El trabajo intermediado por plataformas en Colombia: aspectos conceptuales y propuesta de regulación desde la teoría de contratos y la organización industrial 0 0 0 8 0 0 3 9
Genetic testing with primary prevention and moral hazard 0 0 0 48 0 9 11 197
Genetic testing with primary prevention and moral hazard 0 0 0 28 0 0 0 96
Genetic testing with primary prevention and moral hazard 0 0 0 14 0 0 0 77
Genetic testing with primary prevention and moral hazard 0 0 0 14 0 0 1 73
Genetic testing with primary prevention and moral hazard 0 0 0 19 0 0 1 82
Healt care network formation and policyholders'welfare 0 0 0 30 0 6 7 158
Health Care Insurance Payment Policy when the Physician and Patient May Collude 0 0 1 20 0 0 2 62
Health Care Insurance Payment Policy when the Physician and Patient May Collude 0 0 0 9 0 0 2 92
Health Care Network Formation and Policyholders' Welfare 0 0 1 48 0 0 2 135
Health Care Providers Payments Regulation when Horizontal and Vertical Differentiation Matter 0 0 0 133 0 0 0 425
Health Care Providers Payments Regulation when Horizontal and Vertical Differentiation Matter 0 0 0 57 0 0 0 201
Health Insurance and Diversity of Treatment: A Policy Mix Perspective 0 0 0 36 1 1 2 117
Health care insurance payment policy when the provider and patient May Collude 0 0 0 0 0 0 1 3
Health insurance and diversity of treatment: a policy mix perspective 0 0 0 28 0 0 1 81
How Is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment 0 0 0 35 0 0 1 120
How Is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing?: Theory and Experiment 0 0 1 58 0 1 2 65
How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment 0 0 0 63 0 0 0 78
Informality and Optimal Public Policy 0 0 0 35 0 0 0 46
Informality and Optimal Public Policy 1 1 1 42 1 3 4 147
Integración vertical en el sector de la salud colombiano 0 0 2 56 0 1 5 156
La economía de los mercados de dos lados: aplicación al análisis de las tarjetas de pago en Colombia 0 0 2 201 0 0 5 843
Nursing Homes' Competition and Distributional Implications when the Market is Two-Sided 0 0 0 34 0 0 0 61
Nursing Homes’ Competition and Distributional Implications when the Market is Two-Sided 0 0 0 14 0 0 0 66
Nursing homes' competition and distributional implications when the market is two-sided 0 0 0 7 0 0 1 13
Personalized Medicine and Prevention: Can Cross-Subsidies Survive in the Health Insurance Markets ? 0 0 24 24 0 1 6 6
Physicians' Incentives to Adopt Personalized Medicine: Experimental Evidence 0 1 1 42 0 1 5 37
Physicians’ Incentives to Adopt Personalized Medicine: Experimental Evidence 0 0 0 9 0 1 4 28
Physicians’ incentives to adopt personalised medicine: Experimental evidence 0 0 1 9 0 0 2 15
Physicians’ incentives to adopt personalized medicine: experimental evidence 0 1 1 6 2 3 6 50
Physicians’ incentives to adopt personalized medicine: experimental evidence 0 0 0 45 0 0 2 39
Precios máximos de venta en el mercado de medicamentos colombiano: una evaluación de impacto 0 0 0 29 0 0 2 103
Price cap regulation in the Colombian pharmaceutical market: An impact evaluation 0 0 3 9 0 0 8 29
Price cap regulation in the Colombian pharmaceutical market: An impact evaluation 0 0 2 9 0 1 8 43
Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry 0 0 0 85 0 0 3 299
Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry 0 0 0 308 1 1 2 858
Seguros de desempleo: revisión de literatura y propuesta para Colombia 0 0 3 204 1 1 5 863
Small-area variation in health care affecting the choice of cesarean delivery: the case of a colombian health insurer 0 0 0 81 0 14 17 407
Supplementary health insurance in the Colombian managed care system: Adverse or advantageous selection? 0 0 0 33 0 0 2 46
Supplementary health insurance in the Colombian managed care system: ¿Adverse or advantageous selection? 0 0 0 12 1 2 2 57
Teoría del control óptimo: ¡Una guía para principiantes! 0 0 3 1,160 0 1 14 3,832
Teorías y algunas experiencias internacionales en el financiamiento de la educación superior: lecciones para Colombia 0 0 0 182 0 15 22 1,183
The Design of Insurance Coverage for Medical Products under Imperfect Competition 0 0 0 7 0 0 0 74
The Design of Insurance Coverage for Medical Products under Imperfect Competition 0 0 0 19 0 0 0 75
The design of insurance coverage for medical products under imperfect competition 0 0 0 9 0 0 1 75
The design of insurance coverage for medical products under imperfect competition 0 0 0 22 0 0 0 77
The regulation of health care providers' payments when horizontal and vertical differentiation matter 0 0 0 2 0 0 2 46
Unemployment Insurance in the Presence of an Informal Sector 0 0 1 81 0 0 7 199
Unemployment insurance and informality in developing countries 0 0 1 75 0 0 3 148
Unemployment insurance and informality in developing countries 0 0 0 108 1 1 1 316
Unemployment insurance in the presence of an informal 0 0 1 43 0 6 11 134
Voluntary Health Plan Subsidies and Public Expenditure 0 0 0 19 0 0 0 66
Voluntary Health Plan Subsidies and Public Expenditure 0 0 0 5 1 1 1 50
Voluntary Health Plan Subsidies and Public Expenditure 0 0 0 16 0 1 1 76
Welfare Impacts of Genetic Testing in Health Insurance Markets: Will Cross-Subsidies Survive? 0 0 0 4 0 0 1 40
¿Tiene efectos negativos el TLC sobre los precios de los medicamentos y la salud de los colombianos? 0 0 0 145 0 13 16 1,096
Total Working Papers 2 4 66 5,835 12 125 318 18,449
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A paradoxical risk aversion effect on the consumers' demand for quality 0 0 0 13 0 0 0 71
Competencia en el sector de la salud: énfasis en el caso colombiano 0 0 0 14 0 0 1 88
Competition Among Health Plans: A Two‐Sided Market Approach 0 0 0 85 0 0 2 253
Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets 0 0 0 4 0 0 1 50
Competition in Two-Sided Markets with Common Network Externalities 0 0 0 35 0 1 2 106
Concentration of the mobile telecommunications markets and countries’ competitiveness 0 1 5 7 0 3 17 25
Contrat d'assurance maladie optimal et risque moral ex ante. Quand peut-on s'affranchir d'une franchise ? 0 0 1 13 0 0 2 99
Controlling Sellers Who Provide Advice: Regulation and Competition 0 0 4 9 0 1 11 38
Demande induite et réglementation de médecins altruistes 0 0 0 6 0 0 0 91
Demande induite et réglementation de médecins altruistes 0 0 0 7 0 0 0 69
Doctors' Remuneration Schemes and Hospital Competition in a Two-Sided Market 0 0 0 22 0 1 1 104
Efficacité et risque moral ex post en assurance maladie 0 0 0 18 0 0 1 114
Estimation de l'efficience des dépenses de santé au niveau départemental par la méthode DEA 0 0 1 9 0 0 2 27
Estimation de l’efficience des dépenses de santé au niveau départemental par la méthode DEA 0 0 1 7 0 0 3 27
Genetic testing with primary prevention and moral hazard 0 0 0 17 0 1 2 103
Gestion des risques longs et comportements de risque moral sur les marchés d'assurance maladie la première inefficacité peut-elle éliminer la seconde ? 0 0 0 5 0 0 0 24
Health Care Network Formation and Policyholders' Welfare 0 0 1 29 0 0 1 130
Health care insurance policies When the provider and patient may collude 0 1 4 17 0 1 9 58
Health insurance and diversity of treatment 0 1 2 30 0 1 2 92
How is the trade-off between adverse selection and discrimination risk affected by genetic testing? Theory and experiment 1 1 1 8 1 1 1 49
Informality and Optimal Public Policy 0 0 1 16 0 0 4 47
Integración vertical en el sector colombiano de la salud 0 0 1 14 1 1 3 53
La regulación de tarifas en el sector de la salud en Colombia 0 0 0 52 0 0 1 215
Médecine personnalisée, tests génétiques et assurance santé: une tension exacerbée entre antisélection et discrimination des risques 0 0 0 7 0 2 2 31
Nursing‐homes' competition and distributional implications when the market is two‐sided 0 0 0 3 0 0 4 11
Optimal health insurance contract: Is a deductible useful? 0 0 0 145 0 1 4 424
Optimal regulation of health system with induced demand and 'ex post' moral hazard 0 0 0 24 0 0 2 64
Physicians’ incentives to adopt personalised medicine: Experimental evidence 0 0 0 3 0 0 4 21
Retail price regulation and innovation: Reference pricing in the pharmaceutical industry 0 1 1 82 1 4 5 369
Supplemental health insurance in the Colombian managed care system: Adverse or advantageous selection? 0 1 1 16 0 2 5 74
The design of insurance coverage for medical products under imperfect competition 0 0 0 29 0 0 1 155
The regulation of health care providers’ payments when horizontal and vertical differentiation matter 0 1 1 46 0 2 3 158
Unemployment Insurance in the Presence of an Informal Sector 0 0 0 23 0 0 0 79
Total Journal Articles 1 7 25 815 3 22 96 3,319


Statistics updated 2024-02-04